Showing results (1261-1270 of 2,642) with videos related to
Sort By:
Pageof 265
Hematology (Amsterdam, Netherlands)|June 30, 2015
Autophagy governs erythroid differentiation both in vitro and in vivoYan Cao, Jinyang Cai, Xin Li, et al.Hematology (Amsterdam, Netherlands)|April 18, 2012
Hematopoietic stem cell transplantation in Europe. Differences between Eastern and Western countriesAlvaro Urbano-Ispizua, Helen Baldomero, Alois GratwohlHematology (Amsterdam, Netherlands)|June 11, 2026
Real-world pegcetacoplan treatment of paroxysmal nocturnal hemoglobinuria patients with an unsatisfactory response to prior therapiesCarlos Vallejo, Carmen González, Anna Gaya, et al.Hematology (Amsterdam, Netherlands)|July 11, 2026
Effectiveness and safety of brentuximab vedotin-containing regimen versus standard chemotherapy in relapsed or refractory Hodgkin lymphoma: a multicenter cohort studyAbdullah M Alrajhi, Bashayer Alshehri, Walaa A Alshahrani, et al.Hematology (Amsterdam, Netherlands)|July 11, 2026
Temporal trends and global comparison of the burden of thalassemia in China: an analysis of the Global Burden Of Disease Study 2021Changqun He, Meiting Long, Yiming Yang, et al.Hematology (Amsterdam, Netherlands)|July 13, 2026
The role of von Willebrand factor in gastrointestinal angiodysplasia and obscure gi bleeding: a narrative reviewOjan Ghodsi, Ali Ghasemi, Saleh AhangariHematology (Amsterdam, Netherlands)|June 6, 2012
Study of clinical and aetiological profile of 100 patients of pancytopenia at a tertiary care centre in IndiaDhaval Doshi, Asha N Shah, Shrikant Somani, et al.Hematology (Amsterdam, Netherlands)|July 28, 2026
Highly suppressive functional CCR7 low Treg subset cells may correlate with poor prognosis of B-ALLSui Songnan, Jiamian Zheng, Jing Lai, et al.Hematology (Amsterdam, Netherlands)|September 3, 2026
Integrative bioinformatic analysis delineates a mitochondrial-hematopoietic gene signature for diagnosis and immune characterization in myelodysplastic syndromesXianchuan Liu, Hong Zhang, Xiangzhu LiHematology (Amsterdam, Netherlands)|September 5, 2026
Outcomes of patients with myelofibrosis treated with ruxolitinib and anemia-supporting medicationsPankit Vachhani, Jennifer Repp, J E Hamer-Maansson, et al.Pageof 265